C-H Li

发表

The First Data Release (DR1) of the LAMOST general survey

G. Zhao, H. Chen, J. Carlin, 2015, 1505.01570.

Analysis on the correlation factors for hemorrhagic transformation after intravenous thrombolytic therapy.

Y-Q Li, C-H Li, Y. Chen, 2015, European review for medical and pharmacological sciences.

Study on the effect of urinary kallidinogenase after thrombolytic treatment for acute cerebral infarction.

Z. Wang, C-H Li, Y. Chen, 2015, European review for medical and pharmacological sciences.

Observation of clinical efficacy of rt-PA intravenous thrombolytic treatment for patients combined with grade 0-1 diabetic foot by Wagner classification and acute ischemic stroke.

Z. Wang, Z. Lv, C-H Li, 2016, European review for medical and pharmacological sciences.

Analysis of related factors of orolingual angioedema after rt-PA intravenous thrombolytic therapy.

Z. Wang, Y-Q Li, C-H Li, 2018, European review for medical and pharmacological sciences.

MiR-199 inhibits EMT and invasion of hepatoma cells through inhibition of Snail expression.

C-H Li, H-Y Zhang, J. Chen, 2019, European review for medical and pharmacological sciences.

LncRNA GAS5 overexpression alleviates the development of osteoporosis through promoting osteogenic differentiation of MSCs via targeting microRNA-498 to regulate RUNX2.

C-H Li, J. Feng, J-X Wang, 2019, European review for medical and pharmacological sciences.

Clinical study of the radiotherapy with EDGE accelerator in the treatment of the moderate and severe thyroid associated ophthalmopathy.

C-H Li, L. Zeng, X-Q Xie, 2019, European review for medical and pharmacological sciences.

Reduced long noncoding RNA PGM5-AS1 facilitated proliferation and invasion of colorectal cancer through sponging miR-100-5p.

C-H Li, B. Zhou, Y. Cheng, 2020, European Review for Medical and Pharmacological Sciences.